NRXP NRX PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2025 - Stock Purchase Agreement NRX Pharmaceuticals has entered into an agreement to sell 732,600 shares of its common stock at $2.73 each to an investor, with plans for a total investment of at least $25 million in its subsidiary, Hope Therapeutics, which includes various financial terms and rights for the investor.Get access to all SEC 8-K filings of the NRX PHARMACEUTICALS INC